How a global pharmaceutical company replaced static enrollment forecasts with real-time predictions, early intervention, and smarter resource allocation.
The Challenge
Managing a multi-country, multi-site Phase 3 program, the client could not translate enrollment data into actionable decisions. Their forecasting tools produced fragmented outputs requiring manual interpretation, reporting varied by producer and format, and their R-based analytics environment could not connect to visualization tools. Leadership had no consistent way to compare site or country performance, and delays were identified too late to intervene effectively.
The Approach
Axtria deployed a three-phase Bayesian enrollment modeling solution. In the first phase, the model was initialized using historical benchmarks from CTMS, EDC, and registry data, then continuously updated as real-time recruitment data accumulated. In the second phase, the engine generated probability distributions of site-level recruitment rates, capturing variability across centers. In the third phase, the solution aggregated site outputs into decision-ready insights estimating minimum site requirements, flagging at-risk sites, and tracking the probability of on-time completion.
The Outcome
Study teams moved from static, retrospective forecasting to real-time predictive intelligence that adapted as new data emerged. Underperforming sites were identified early, enabling targeted intervention before minor delays became major timeline impacts. Site deactivation decisions became data-driven, reducing unnecessary costs. Reporting was standardized across functions, eliminating manual reformatting and giving leadership a single source of truth for country-level cost-efficiency comparisons.
What You Will Learn
- How a Bayesian Poisson-Gamma engine replaces static benchmarks with continuously updated, site-level enrollment forecasts.
- How to connect R-based modeling environments to standardized visualization pipelines without manual intervention.
- How probabilistic site evaluation supports proactive decisions on activation and deactivation, protecting timelines and budgets.
- How standardized reporting across countries and functions accelerates consensus and reduces time spent debating data validity.
Conclusion
By moving from static enrollment benchmarks to a dynamic, Bayesian-powered forecasting engine, this pharmaceutical company rebuilt its ability to manage clinical trial recruitment. The key principle: enrollment forecasting creates the most value when statistical rigor connects directly to operational decisions. When models update continuously, surface actionable alerts, and deliver insights in decision-ready formats, enrollment transforms from a reactive reporting exercise into a strategic capability, protecting timelines, optimizing costs, and accelerating patient access.
FAQs
